Lupin to acquire French pharmaceutical company Medisol
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
The partnership will capitalize on the combined capabilities of the two organizations
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
The return profile of NCDs is linked to BBL share price subject to minimum IRR of 12%.
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
SÜDPACK is setting standards in terms of both performance and sustainability
The data highlight the three drug candidates' potential for clinical development and promising synergistic utilities in new indications
The session took place in the presence of Union Ministers Hardeep Singh Puri and Gen V K Singh along with Anil Agarwal, Rajya Sabha Member of Parliament
The introduction of Octasa 1600 mg to the Canadian market is expected to increase the options for UC patients managed with mesalazine.
Microsoft Cloud for Healthcare and Cognizant’s TriZetto healthcare products aim to enhance transparency for consumers and increase interoperability for providers and payers
Subscribe To Our Newsletter & Stay Updated